AIkido Pharma Announces Peer-Reviewed Publication of Positive Results from Study of Antiviral Compounds Licensed from University of Maryland, Baltimore

Stock Information for AIkido Pharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About AIkido Pharma Inc.

AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH)
AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes
AIkido Share Repurchase Continues
AIkido Purchases More Shares
Share Repurchase Program Continues
AIkido Pharma Continues Share Repurchase Program
AIkido Pharma Provides Update on Share Repurchase Program
Dominari Financial, Inc. Executes Definitive Agreement to Buy Broker-Dealer

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.